How have Tenaya Therapeutics Inc (TNYA)’s performance and profitability changed over the time?

Tenaya Therapeutics Inc [TNYA] stock prices are up 8.51% to $3.57 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TNYA shares have gain 65.28% over the last week, with a monthly amount glided 74.15%, and seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Previously, Leerink Partners started tracking the stock with Outperform rating on November 30, 2023, and set its price target to $7. On June 15, 2022, H.C. Wainwright initiated with a Buy rating and assigned a price target of $25 on the stock.

The stock price of Tenaya Therapeutics Inc [TNYA] has been fluctuating between $1.61 and $7.01 over the past year. Tenaya Therapeutics Inc [NASDAQ: TNYA] shares were valued at $3.57 at the most recent close of the market.

Analyzing the TNYA fundamentals

Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at -6.95%, Pretax Profit Margin comes in at -6.64%, and Net Profit Margin reading is -6.64%. To continue investigating profitability, this company’s Return on Assets is posted at -0.83, Equity is -0.86 and Total Capital is -0.99.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.26 points at the first support level, and at 2.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.78, and for the 2nd resistance point, it is at 3.98.

Ratios To Look Out For

It’s worth pointing out that Tenaya Therapeutics Inc [NASDAQ:TNYA]’s Current Ratio is 5.27. Further, the Quick Ratio stands at 5.27, while the Cash Ratio is 0.51.

Transactions by insiders

Recent insider trading involved Saito Chihiro, SVP, Accounting and Fin. Ops., that happened on Nov 18 ’24 when 2258.0 shares were sold. SVP, Accounting and Fin. Ops., Saito Chihiro completed a deal on Aug 16 ’24 to sell 2363.0 shares. Meanwhile, Chief Medical Officer Tingley Whittemore sold 7428.0 shares on Aug 16 ’24.

Related Posts